|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Olmesartan ethyl este
|
奥美沙坦乙酯
|
|
|
Olmesartan medoxomil impurity III
|
奥美沙坦酯杂质III
|
|
|
Olmesartan medoxomil impurity V
|
奥美沙坦酯杂质V
|
|
|
Trityl olmesartan impurity I
|
三苯甲基奥美沙坦酯杂质I
|
|
|
Trityl olmesartan impurity II
|
三苯甲基奥美沙坦酯杂质II
|
|
|
Trityl olmesartan impurity III
|
三苯甲基奥美沙坦酯杂质III
|
|
|
Olmesartan medoxomil impurity IV
|
奥美沙坦酯杂质IV
|
1040250-19-8
|
|
Quinazoline, 2-(chloromethyl)-4-methyl-
|
2-氯甲基-4-甲基喹唑啉
|
109113-72-6
|
|
Olmesartan intermediate impurity IV
|
咪唑单乙酯杂质IV
|
1092980-84-1
|
|
[1,1'-Biphenyl]-4-carboxylic acid,hexahydro-2-oxo-4-(3-oxodecyl)-2H-cyclopenta[b]furan-5-yl ester,[3aR-(3a,4,5,6a)]-
|
[1,1'-联苯]-4-羧酸,六氢-2-氧代-4-(3-氧代癸烯基)-2H-环戊并[b]呋喃-5-基酯,[3aR-(3a,4,5,6a)]-
|
120373-45-7
|
|
Olmesartan intermediate impurity II
|
咪唑单乙酯杂质II
|
144690-07-3
|
|
1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetraz ol-5-yl][1,1'-biphenyl]-4-yl]methyl]-, ethyl ester
|
三苯甲基奥美沙坦乙酯
|
144690-33-5
|
|
(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester
|
(5R-CIS)-甲苯-4-磺酸 5-(2,4-二氟苯基)-5-(1H-1,2,4-三氮唑-1-基)甲基四氢呋喃-3-基甲基酯(泊沙康唑主环)
|
149809-43-8
|
|
Olmesartan intermediate impurity VI
|
咪唑单乙酯杂质VI
|
157356-73-5
|
|
(S)-N-[[3-[3-Fluoro-4-[4-morpholinyl]phenyl]-2-oxo-5-oxazolidinyl]methyl]amine
|
(S)-5-(氨基甲基)-3-(3-氟-4-吗啉基苯基)-2-唑烷酮
|
168828-90-8
|
|
Olmesartan intermediate impurity I
|
咪唑单乙酯杂质V
|
172875-53-5
|
|
3-Carbamoymethyl-5-methylhexanoic acid
|
3-氨基甲酰甲基-5-甲基己酸
|
181289-15-6
|
|
(R)-(-)-3-(Carbamoymethyl)-5-methylhexanoic acid
|
(R)-(-)-3-氨基甲酰甲基-5-甲基己酸
|
181289-33-8
|
|
2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one
|
2-[(1S,2S)-1-乙基-2-苄氧基丙基]-2,4-二氢-4-[4-[4-(4-羟基苯基)-1-哌嗪基]苯基]-3H-1,2,4-三氮唑-3-酮(泊沙康唑侧链)
|
184177-83-1
|
|
1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride
|
1-乙基-(3-二甲氨基丙基)碳酰二亚胺盐酸盐
|
25952-53-8
|
|
(3aR,6aS)-3,3a,6,6a-tetrahydro-2H-cyclopenta[b]furan-2-one
|
(1R,5S)-2-氧杂二环[3.3.0]辛-6-烯-3-酮
|
26054-46-6
|
|
(R)-3-(Boc-Amino)piperidine
|
(R)-3-Boc-氨基哌啶
|
309956-78-3
|
|
(-)-Corey Lactone Benzoate
|
(3aR,4S,5R,6aS)-5-(苯甲酰氧基)六氢-4-(羟基甲基)-2H-环戊并[b]呋喃-2-酮
|
39746-00-4
|
|
[1,1'-Biphenyl]-4-carboxylic acid,(3aR,4R,5R,6aS)-hexahydro-4-[(1E,3S)-3-hydroxy-1-octen-1-yl]-2-oxo-2H-cyclopenta[b]furan-5-yl ester
|
[1,1'-联苯]-4-羧酸,(3aR,4R,5R,6aS)-六氢-4-[(1E,3S)-3-羟基-1-辛烯-1-基]-2-氧代-2H-环戊并[b]呋喃-5-基酯
|
51014-26-7
|
|
(R)-N-(4-nitrophenethyl)-2-hydroxy-2-phenylacetamide
|
(R)-2-羟基-N-(4-硝基苯乙基)-2-苯基乙酰胺
|
521284-19-5
|
|
(alphaR)-alpha-[[[2-(4-Nitrophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride
|
(R)-2-(4-硝基苯乙基氨基)-1-苯基乙醇盐酸盐
|
521284-21-9
|
|
8-bromo-7-but-2-yn-1-yl-3-methyl-3,7-dihydro-1H-purine-2,6-dione
|
8-溴-7-(2-丁炔基)-3,7-二氢-3-甲基-1H-嘌呤-2,6-二酮
|
666816-98-4
|
|
2(1H)-Pentalenone, 5-(benzoyloxy)hexahydro-4-(hydroxymethyl)-, [3aS-(3a,4,5,6a)]-
|
2(1H)-并环戊二烯酮,5-(苯甲酰氧基)六氢-4-(羟甲基)-,[3aS-(3a,4,5,6a)]-
|
74842-93-6
|
|
Trityl olmesartan acid
|
三苯甲基奥美沙坦酸
|
761404-85-7
|
|
(3as,4R,5S,6ar)-(+)-hexahydro-5-hydroxy-4-hoch2-2
|
(3aS,4R,5S,6aR)-六氢-5-羟基-4-(羟甲基)-2H-环戊并[b]呋喃-2-酮
|
76704-05-7
|
|
4-(chloromethyl)-5-methyl-1,3-dioxol-2-one
|
4-氯甲基-5-甲基-1,3-二氧杂环戊烯-2-酮
|
80841-78-7
|
|
1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine
|
8-溴-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-[(4-甲基-2-喹唑啉基)甲基]-1H-嘌呤-2,6-二酮
|
853029-57-9
|
|
Benzonitrile, 2-[(6-chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-
|
2-[(6-氯-3,4-二氢-3-甲基-2,4-二氧代-1(2H)-嘧啶基)甲基]苯甲腈
|
865758-96-9
|
|
4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-Imidazole-5-carboxylic acid(5-methyl-2-oxo-1,3-dioxol-4-yl)methylester
|
奥美沙坦酯杂质I
|
879562-26-2
|
|
Olmesartan medoxomil impurity II
|
奥美沙坦酯杂质II
|
896419-17-3
|
|
1,3-Dioxol-2-one, 4-(hydroxymethyl)-5-methyl-
|
4-羟甲基-5-甲基-1,3-二氧杂环戊烯-2-酮
|
91526-18-0
|
|
3-Methyl-8-bromoxanthine
|
8-溴-3-甲基-3,7-二氢-嘌呤-2,6-二酮
|
93703-24-3
|